The US Food and Drug Administration (FDA) has notified Bayer that it has extended the review period for the New Drug ...

Privately-held Swiss biotech Memo Therapeutics has announced results from its Phase II trial evaluating potravitug, a ...

US pharma major Bristol Myers Squibb revealed it has appointed Dr Cristian Massacesi as executive vice president, chief medical officer and head of development, effective August 1, 2025.